Close Menu

Fabric Genomics

By Uduak Grace Thomas
As genome sequencing continues to makes inroads into clinics, established vendors and small startups are honing their informatics portfolios to tap into the growing market for software in this setting.

Omicia is implementing the approach, dubbed VAAST, in the Genome Analysis System, a platform it is developing for the clinical analysis of human genomes that it plans to launch in the third quarter under a software-as-a-service model.

Omicia, which co-developed VAAST with Mark Yandell’s group at the University of Utah, is now working on integrating the algorithm into a platform called the Genome Analysis System, which it plans to release commercially at the end of the third quarter.

Paired Ends: Jul 20, 2010

Premium

Melina Cimler, Jacques Simard, Harlan Robins, Christopher Carlson, Chad Robins, Jessica Andriesen, Robert Livingston, Andris Zoltners, Arnold Levine, Jerry Nepom, Jay Shendure, Edus Warren, Graham Allen, Matt Kahn, Peter Keane, Richard Mitchell, Josh Rosen, Craig Weissman, Martin Reese, Edward Kiruluta, Paul Billings, John Stuelpnagel, Michael Ashburner, Pui-Yan Kwok, George Miklos, James Scott, Terry Speed, John Witte

Last month, the company inked its first commercial partnership by joining the Genomic Cancer Care Alliance, which is spearheaded by Life Technologies.

An Omicia spokesperson told BioInform that the company will work closely with the sequencing companies in the alliance to process, annotate, and interpret raw cancer genome data and convert it into a useful format for clinicians.

The Genomic Cancer Care Alliance — which currently involves founding organizations Fox Chase Cancer Center, Scripps Genomic Medicine, Omicia, El Camino Hospital, and the Translational Genomics Research Institute — plans to launch a pilot study to investigate the ability of whole-genome sequencing to guide treatment for patients who have responded poorly to initial therapy.

The alliance is primarily funded by Life Technologies for now and will use the company's SOLiD 4 sequencing platform. Other founding partners include the Fox Chase Cancer Center, Scripps Genomic Medicine, and the Translational Genomics Research Institute.

Pages

A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.